PMS16 - Cost Per-Responder Analysis of Secukinumab Compared To Adalimumab For The Treatmenmt of Ankylosing Spondylitis Over One Year In Saudi Arabia

Journal article

Open access

Peer reviewed

H Al Mudaiheem, M Al Howimel, K Al Jufan, H Al Hamdan, A AlAlwan, N Alshehri, N Zakaria, L Al Kateb and G Ramakrishna

Value in health, Vol.21, pp.S81-S82

09/2018

Files and links (1)

url

https://doi.org/10.1016/j.jval.2018.07.609View

Published (Version of record) Open

1 Record Views

Title: PMS16 - Cost Per-Responder Analysis of Secukinumab Compared To Adalimumab For The Treatmenmt of Ankylosing Spondylitis Over One Year In Saudi Arabia
Creators - without role: H Al Mudaiheem - Ministry of Health
M Al Howimel - National Guard Health Affairs
K Al Jufan - National Guard Health Affairs
H Al Hamdan - King Abdulaziz Medical City
A AlAlwan - Riyadh Armed Forces Hospital
N Alshehri - Riyadh Armed Forces Hospital
N Zakaria - Novartis, Riyadh, Saudi Arabia
L Al Kateb - Novartis, Riyadh, Saudi Arabia
G Ramakrishna - Novartis
Publication Details: Value in health, Vol.21, pp.S81-S82
Publisher: Elsevier Inc
Identifiers: 9921676308331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article